Novavax (NVAX) Stock
NASDAQ · NVAX
10.11
Fundamentals
Market cap
$1.67B
Price / Earnings ratio
-6.7x
Price / Sales ratio
4.0x
Price / Book ratio
-8.7x
Return on assets
-0.1%
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.0%
Debt / Equity ratio
N/A
Latest news
About Novavax
Novavax, Inc. is a biotechnology company that promotes improved health globally through the discovery, development and commercialization of innovative vaccines to prevent serious infectious diseases. The company's proprietary recombinant technology platform combines the power and speed of genetic engineering to efficiently produce highly immunogenic nanoparticles designed to address urgent global health needs.
SectorHealthcare
IndustryBiotechnology
Employees749
CEOMr. John Charles Jacobs M.B.A.
IPO DateDec 5, 1995
HeadquartersGaithersburg, MD
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. John Charles Jacobs M.B.A. | President, CEO & Director | 1967 |
| Mr. James Patrick Kelly C.F.A. | Executive VP, CFO & Treasurer | 1966 |
| Mr. Mark J. Casey Esq., J.D. | Executive VP, Chief Legal Officer & Corporate Secretary | 1963 |
| Ms. Elaine O'Hara | Executive VP & Chief Strategy Officer | 1968 |
| Mr. Richard P. Crowley | Executive VP & COO | 1957 |
| Ms. Naina Zaman | Director of Investor Relations | — |
| Mr. Troy Morgan Esq., J.D. | Senior VP, Deputy General Counsel & Chief Compliance Officer | 1971 |
| Ms. Erika S. Trahan | Associate Director of Investor & Public Relations | — |
| Mr. Ian J. Watkins | Executive VP & Chief Human Resources Officer | 1963 |
| Ms. Silvia Taylor M.B.A. | Executive VP, Chief Corporate Affairs Officer & Head of Novavax Sweden | — |
Fundamentals
Valuation
Market cap$1.67B
Price-to-sales ratio3.99
Price-to-book value-8.65
Price-earnings ratio-6.70
Return on Equity90.00%
Return on SalesN/A
Return on AssetsN/A
PEG ratio1.32
Earnings Per Share
Earnings Per Share$-1.52
Income Statement
Average volume5,779,288
EBITDA$-42.13M
1 year high (52w)$11.97
1 year low (52w)$6.20
Dividend
Ex dividend dateN/A
Dividend amount$0.00
Dividend yield0.00%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A



